Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	43.58	35.44	11.36	55.74	32.59	9.5
Short-Term Investments	0.05	0.05	46.52	2.62	8.98	21.22
Cash & Short-Term Investments	43.62	35.49	57.88	58.36	41.56	30.72
Cash Growth	-6.82%	-38.67%	-0.83%	40.41%	35.31%	-0.08%
Receivables	0.08	0.75	0.3	50.84	0	23.94
Prepaid Expenses	2.02	2.18	1.83	2.35	2.36	2.86
Restricted Cash	-	-	-	-	0.08	-
Other Current Assets	-	0.02	-	-	-	-
Total Current Assets	45.72	38.44	60	111.55	44	57.52
Property, Plant & Equipment	4.96	4.77	5.67	4.87	5.63	8.18
Goodwill	10.67	10.67	10.67	10.67	10.67	10.67
Other Intangible Assets	46.54	46.56	46.69	46.82	47.03	48.25
Other Long-Term Assets	0.6	0.58	0.63	0.63	0.62	0.86
Total Assets	108.48	101.02	123.66	174.55	107.95	125.48
Accounts Payable	2.21	2.05	2.39	3.54	2.61	2.43
Accrued Expenses	3.47	4.22	6.22	24.25	3.67	2.8
Short-Term Debt	-	-	-	-	0.52	-
Current Portion of Leases	1.1	0.88	0.95	0.83	0.76	1.22
Current Unearned Revenue	10.11	10.81	9.42	18.12	0.19	0.05
Other Current Liabilities	-	-	-	0.38	0.01	0
Total Current Liabilities	16.89	17.96	18.98	47.12	7.77	6.49
Long-Term Leases	2.15	2.07	2.94	1.97	2.54	3.95
Long-Term Unearned Revenue	18.18	18.69	27.73	32.45	-	0.2
Long-Term Deferred Tax Liabilities	0.27	0.27	2.08	2.08	2.08	3.32
Other Long-Term Liabilities	-	-	0	0.03	0.44	0.28
Total Liabilities	37.49	39	51.73	83.65	12.82	14.23
Common Stock	466.57	451.34	440.28	434.53	393.94	387.06
Retained Earnings	-391.4	-384.86	-363.37	-337.1	-294.08	-273.42
Comprensive Income & Other	-2.77	-3.07	-3.57	-5.21	-3.67	-0.68
Total Common Equity	72.4	63.42	73.34	92.22	96.2	112.96
Minority Interest	-1.41	-1.4	-1.4	-1.32	-1.07	-1.71
Shareholders' Equity	70.99	62.02	71.94	90.9	95.13	111.25
Total Liabilities & Equity	108.48	101.02	123.66	174.55	107.95	125.48
Total Debt	3.25	2.95	3.9	2.8	3.83	5.17
Net Cash (Debt)	40.37	32.54	53.98	55.56	37.74	25.55
Net Cash Growth	-6.51%	-39.72%	-2.84%	47.22%	47.71%	-10.28%
Net Cash Per Share	0.23	0.19	0.32	0.34	0.25	0.18
Filing Date Shares Outstanding	188.8	188.53	170.15	169.71	161.64	149.81
Total Common Shares Outstanding	188.75	174.99	170.09	169.48	153.1	149.8
Working Capital	28.83	20.48	41.02	64.43	36.23	51.03
Book Value Per Share	0.38	0.36	0.43	0.54	0.63	0.75
Tangible Book Value	15.19	6.19	15.98	34.73	38.5	54.04
Tangible Book Value Per Share	0.08	0.04	0.09	0.20	0.25	0.36
Machinery	3.6	3.61	3.26	3.47	3.63	4.15
Leasehold Improvements	2.28	2.31	2.15	2.54	2.47	2.86

Source: S&P Capital IQ. Standard template.